The manufacturing shift to meet growing cell and gene therapy demand, applying lessons from the Covid-19 pandemic to address ...

The companies will collaborate to hold a global Phase I combination trial of YL201 and Amgen’s Imdelltra for small cell lung ...

Less frequent dosing could provide Eli Lilly’s Ebglyss room to rival Sanofi and Regeneron’s blockbuster Dupixent.

Bayer has entered a collaboration with MOMA Therapeutics in which the two companies will advance a small molecule oncology ...

Innovent Biologics and ASK Pharm have signed a strategic partnership for the commercialisation of limertinib for the ...

The MHRA’s 2024/25 business plan focuses on improving service delivery for its customers, enabling access to new technologies ...

The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and ...